Jardiance (empagliflozin
In Context ∙ The apex drug regulatory body Central Drugs Standard Control Organisation (CDSCO), has approved use of Jardiance for treating kidney failure. About ∙ The drug Jardiance (empagliflozin) 10mg tablets has been approved to reduce the risk of sustained decline in estimated glomerular filtration rate (eGFR) which is done to check how well the […]
Jardiance (empagliflozin Read More »
Current Affairs

